NewAmsterdam Pharma (NAMS) Revenue (2023 - 2026)
NewAmsterdam Pharma's Revenue came in at $3.7 million for Q2 2026, down 80.7% from $19.15 million a year earlier but up 21.7% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Revenue (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, NewAmsterdam Pharma reported Revenue of $7.12 million, down 88.9% year-over-year; for FY2025, it came in at $22.5 million, down 50.6% from FY2024.
- Revenue carries a three-year compound annual growth rate of -39.7% (FY2022 to FY2025).
- Going back by year, Revenue was $45.56 million in FY2024 (+223.4%), $14.09 million in FY2023 (-86.3%) and $102.69 million in FY2022.
- The five-year range for quarterly Revenue is $32,000 (Q4 2025) to $29.11 million (Q3 2024).
- Year-over-year, Revenue increased in four of the last seven quarters, with growth averaging 209.3%.
- The fastest year-over-year change in Revenue over five years came in Q3 2024 (growth of 889.8%), and the weakest in Q4 2025 (a decline of 99.7%).
- Business Quant data shows NAMS's Revenue at $3.04 million (Q1 2026), $32,000 (Q4 2025) and $348,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | NewAmsterdam Pharma | 2.86 Bn | 2.86 Bn | - | 3.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 348,000.00 |
| Jun 30, 2025 | 19.15 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 12.77 Mn |
| Sep 30, 2024 | 29.11 Mn |
| Jun 30, 2024 | 2.28 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 803,000.00 |
| Sep 30, 2023 | 2.94 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 8.63 Mn |
API Access
NewAmsterdam Pharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();